VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 187 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $263,053 | -79.9% | 60,892 | -69.3% | 0.00% | -100.0% |
| Q2 2023 | $1,306,949 | +18.3% | 198,323 | +21.9% | 0.00% | 0.0% |
| Q1 2023 | $1,105,080 | -7.6% | 162,751 | +0.5% | 0.00% | 0.0% |
| Q4 2022 | $1,196,523 | -24.9% | 161,911 | +0.3% | 0.00% | 0.0% |
| Q3 2022 | $1,594,000 | +81.1% | 161,392 | +100.2% | 0.00% | – |
| Q2 2022 | $880,000 | +145.1% | 80,615 | +153.9% | 0.00% | – |
| Q1 2022 | $359,000 | -27.9% | 31,751 | 0.0% | 0.00% | – |
| Q4 2021 | $498,000 | -8.8% | 31,751 | -0.5% | 0.00% | – |
| Q3 2021 | $546,000 | – | 31,897 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |